Positive effects of cholinergic stimulation favor young APOE η4 carriers

Neuropsychopharmacology

Volumn 35, Issue 5, 2010, Pages 1090-1096

  Marchant, Natalie L ^a   King, Sarah L ^a   Tabet, Naji ^b   Rusted, Jennifer M ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b UNIVERSITY OF BRIGHTON   (United Kingdom)

Author keywords

Apolipoprotein E; Cholinergic system; Cognition; Cognitive enhancement; Nicotine; Prospective memory

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E EPSILON 4; NICOTINE; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CHOLINERGIC STIMULATION; COGNITION; CONTROLLED STUDY; FEMALE; FRONTAL LOBE; GENETIC DIFFERENCE; HETEROZYGOTE; HUMAN; MALE; PRIORITY JOURNAL; TASK PERFORMANCE;

ADOLESCENT; ADULT; AGING; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; COGNITION; DOUBLE-BLIND METHOD; FEMALE; GENOTYPE; HETEROZYGOTE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; NICOTINE; NICOTINIC AGONISTS; NOOTROPIC AGENTS; REACTION TIME; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 77949539859     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2009.214     Document Type: Article

References (33)

1. Alexander DM, Williams LM, Gatt JM, Dobson-Stone C, Kuan SA, Todd EG et al (2007). The contribution of apolipoprotein E alleles on cognitive performance and dynamic neural activity over six decades. Biol Psychol 75: 229-238.
2. Broadbent DE, Cooper PF, FitzGerald P, Parkes KR (1982). The cognitive failures questionnaire (CFQ) and its correlates. Br J Clin Psychol 21(Part 1): 1-16.
3. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW et al (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923.
4. Driscoll I, McDaniel MA, Guynn MJ (2005). Apolipoprotein E and prospective memory in normally aging adults. Neuropsychology 19: 28-34.
5. Farah MJ, Illes J, Cook-Deegan R, Gardner H, Kandel E, King P et al (2004). Neurocognitive enhancement: what can we do and what should we do? Nat Rev Neurosci 5: 421-425.
6. Greely H, Sahakian B, Harris J, Kessler RC, Gazzaniga M, Campbell P et al (2008). Towards responsible use of cognitive-enhancing drugs by the healthy. Nature 456: 702-705.
7. Han SD, Bondi MW (2008). Revision of the apolipoprotein E compensatory mechanism recruitment hypothesis. Alzheimers Dement 4: 251-254.
8. Hubacek JA, Pitha J, Skodova Z, Adamkova V, Lanska V, Poledne R (2001). A possible role of apolipoprotein E polymorphism in predisposition to higher education. Neuropsychobiology 43: 200-203.
9. Lanni C, Lenzken SC, Pascale A, Del Vecchio I, Racchi M, Pistoia F et al (2008). Cognition enhancers between treating and doping the mind. Pharmacol Res 57: 196-213.
10. Levin ED, McClernon FJ, Rezvani AH (2006). Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology 184: 523-539.
11. Marchant NL, Trawley S, Rusted JM (2008). Prospective memory or prospective attention: physiological and pharmacological support for an attentional model. Int J Neuropsychopharmacol 11: 401-411.
12. McNair D, Lorr M, Droppleman L (1971). Profile of Mood States. Edits/ Educational and Industrial Testing Service Inc.: San Diego, CA.
13. Mechaeil R (2009). Exploring the Effects of Losartan on Cognition. Unpublished doctoral dissertation, University of Sussex: Brighton.
14. Mehrabian A, Russell J (1978). A questionnaire measure of habitual alcohol use. Psychol Rep 43: 803-806.
15. Mondadori CR, de Quervain DJ, Buchmann A, Mustovic H, Wollmer MA, Schmidt CF et al (2007). Better memory and neural efficiency in young apolipoprotein E epsilon4 carriers. Cereb Cortex 17: 1934-1947.
16. Muller U, Steffenhagen N, Regenthal R, Bublak P (2004). Effects of modafinil on working memory processes in humans. Psycho-pharmacology (Berl) 177: 161-169.
17. Nelson HE, Willison JR (1991). National Adult Reading Test (NART). Second edn. NFER-NELSON NFER-NELSON: Windsor, Berks.
18. Ossendorf M, Prellwitz W (2000). Rapid and easy apolipoprotein E genotyping using an improved PCR-RFLP technique. Qiagen News 1: 11-13.
19. Poirier J, Delisle MC, Quirion R, Aubert I, Farlow M, Lahiri D et al (1995). Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proc Natl Acad Sci USA 92: 12260-12264.
20. Randall DC, Shneerson JM, File SE (2005). Cognitive effects of modafinil in student volunteers may depend on IQ. Pharmacol Biochem Behav 82: 133-139.
21. Rebeck GW, Reiter JS, Strickland DK, Hyman BT (1993). Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 11: 575-580.
22. Robbins TW (2002). The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology 163: 362-380.
23. Rusted JM (1988). Dissociative effects of scopolamine on working memory in healthy young volunteers. Psychopharmacology 96: 487-492.
24. Rusted JM, Sawyer R, Jones C, Trawley SL, Marchant NL (2009). Positive effects of nicotine on cognition: the deployment of attention for prospective memory. Psychopharmacology 202: 93-102.
25. Rusted JM, Trawley S (2006). Comparable effects of nicotine in smokers and nonsmokers on a prospective memory task. Neuropsychopharmacology 31: 1545-1549.
26. Rusted JM, Trawley S, Heath J, Kettle G, Walker H (2005). Nicotine improves memory for delayed intentions. Psychopharmacology 182: 355-365.
27. Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH et al (1993). Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43: 1467-1472.
28. Savitz J, Solms M, Ramesar R (2006). Apolipoprotein E variants and cognition in healthy individuals: a critical opinion. Brain Res Rev 51: 125-135.
29. Schneider NG, Lunell E, Olmstead RE, Fagerstrom KO (1996). Clinical pharmacokinetics of nasal nicotine delivery. A review and comparison to other nicotine systems. Clin Pharmacokinet 31: 65-80.
30. Thayer RE (1978). Toward a psychological theory of multidimensional activation (arousal). Motiv Emot 2: 1-34.
31. Wesnes K, Warburton DM (1983). Effects of smoking on rapid information processing performance. Neuropsychobiology 9: 223-229.
32. Wright RO, Hu H, Silverman EK, Tsaih SW, Schwartz J, Bellinger D et al (2003). Apolipoprotein E genotype predicts 24-month bayley scales infant development score. Pediatr Res 54: 819-825.
33. Yu YW, Lin CH, Chen SP, Hong CJ, Tsai SJ (2000). Intelligence and event-related potentials for young female human volunteer apolipoprotein E epsilon4 and non-epsilon4 carriers. Neurosci Lett 294: 179-181.